Pick two tickers to compare their income statements as flow diagrams, one shared scale for both.
Key numbers
PFE
Pfizer Inc. Q2 FY2026 income statement
Revenue
$15.0B
Net loss
$248.0M
Net margin
-1.6%
JNJ
Johnson & Johnson Q3 FY2026 income statement
Revenue
$25.4B
Net income
$210.0M
Net margin
+0.8%
PFE's net margin is 2.5 points lower than JNJ's.
PFE
Pfizer Inc. Q2 FY2026 income statement
USD, quarter ended 2026-06-28
JNJ
Johnson & Johnson Q3 FY2026 income statement
USD, quarter ended 2026-09-30
Johnson & Johnson Q3 FY2026 income statementFlow diagram with 7 nodes and 6 flows for Johnson & Johnson Q3 FY2026 income statement. Values: Revenue US$25.4B, Cost of Revenue US$6.9B, Gross Profit US$18.5B, Operating Expenses US$12.2B, Operating Income US$6.4B, Other Expense US$6.3B, Net Income US$210M.RevenueUS$25.4B+6% Y/YCost of Revenue(US$6.9B)-6% Y/Y27% of revenueGross ProfitUS$18.5B+11% Y/Y73% marginOperating Expenses(US$12.2B)+27% Y/YR&D 18% | SG&A 25% of revenue48% of revenueOperating IncomeUS$6.4B-10% Y/Y25% marginOther Expense(US$6.3B)25% of revenueNet IncomeUS$210M-96% Y/Y<1% marginProfitCosts